Dapagliflozin (SGLT2 Inhibitor)
Treatment used for 1 condition
Total Trials
50
Total Participants
50K
Avg Effectiveness
82%
Avg Safety Score
65%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.